- •Foreword
- •Preface
- •List of Contributors
- •Acknowledgments
- •Dedication
- •In Memorium
- •DEFINITIONS
- •EPIDEMIOLOGIC AND SOCIOECONOMIC ASPECTS OF THE GLAUCOMAS
- •RISK FACTORS
- •CLASSIFICATION OF THE GLAUCOMAS
- •REFERENCES
- •Aqueous humor formation
- •FUNCTION OF AQUEOUS HUMOR
- •ANATOMY OF THE CILIARY BODY
- •STRUCTURE
- •ULTRASTRUCTURE OF THE CILIARY PROCESSES
- •VASCULAR SUPPLY
- •MECHANISM OF AQUEOUS FORMATION
- •ULTRAFILTRATION
- •ACTIVE TRANSPORT
- •DIFFUSION
- •CHEMICAL COMPOSITION OF THE AQUEOUS HUMOR
- •THE BLOOD–AQUEOUS BARRIER
- •PRESSURE-DEPENDENT TECHNIQUES
- •Tonography
- •Suction cup
- •Perfusion
- •TRACER METHODS
- •Photogrammetry
- •Radiolabeled isotopes
- •Fluorescein
- •Fluoresceinated dextrans
- •Paraminohippurate
- •Iodide
- •FACTORS AFFECTING AQUEOUS HUMOR FORMATION
- •DIURNAL VARIATION
- •INTRAOCULAR PRESSURE/PSEUDOFACILITY
- •BLOOD FLOW TO THE CILIARY BODY
- •NEURAL CONTROL
- •HORMONAL EFFECTS
- •INTRACELLULAR REGULATORS
- •CLINICAL ASPECTS OF AQUEOUS HUMOR FORMATION
- •CLINICAL CONDITIONS
- •PHARMACOLOGIC AGENTS
- •SURGERY
- •REFERENCES
- •PHYSIOLOGY ISSUES UNIQUE TO THE CONVENTIONAL AQUEOUS OUTFLOW SYSTEM
- •FUNCTIONS OF THE CONVENTIONAL AQUEOUS OUTFLOW SYSTEM
- •ANATOMY OF THE CONVENTIONAL OUTFLOW SYSTEM
- •SCHWALBE’S LINE
- •SCLERAL SPUR
- •TRABECULAR MESHWORK TISSUES
- •Uveal meshwork
- •Corneoscleral meshwork
- •Uveal and corneoscleral meshwork ultrastructure
- •Juxtacanalicular space and cells
- •SCHLEMM’S CANAL
- •Overview
- •Schlemm’s canal inner wall endothelium
- •Glycocalyx
- •Distending cells that form invaginations or pseudovacuoles, ‘giant vacuoles’
- •Schlemm’s canal endothelium pores
- •Sonderman’s canals invaginate into the trabecular meshwork
- •Septa
- •Schlemm’s canal valves spanning across Schlemm’s canal
- •Herniations or protrusions of Schlemm’s canal inner wall
- •Collector channels, aqueous veins and episcleral veins
- •RESISTANCE SITES IN THE AQUEOUS OUTFLOW SYSTEM
- •JUXTACANALICULAR SPACE RESISTANCE
- •SCHLEMM’S CANAL ENDOTHELIUM RESISTANCE
- •PRINCIPLES OF BIOMECHANICS AS A METHODOLOGY TO IDENTIFY TISSUE RESISTANCE
- •TISSUE LOADING STUDIES
- •BOUNDARY CONDITIONS
- •EVIDENCE FROM EXPERIMENTAL MICROSURGERY
- •AQUEOUS OUTFLOW PHYSIOLOGY: PASSIVE AND DYNAMIC FLOW MODELS
- •THE AQUEOUS OUTFLOW SYSTEM AS A PASSIVE FILTER
- •THE AQUEOUS OUTFLOW SYSTEM AS A DYNAMIC MECHANICAL PUMP
- •EXTRINSIC PRESSURE REGULATION MECHANISMS
- •UVEOSCLERAL FLOW
- •METHODS FOR MEASURING FACILITY OF OUTFLOW
- •FACILITY OF OUTFLOW CALCULATIONS
- •Tonography
- •Perfusion
- •Suction cup
- •FACILITY OF OUTFLOW AND ITS CLINICAL IMPLICATIONS
- •FACTORS AFFECTING THE FACILITY OF OUTFLOW
- •HORMONES
- •CILIARY MUSCLE TONE
- •DRUGS
- •SURGICAL THERAPY
- •DIURNAL FLUCTUATION
- •GLAUCOMA
- •EPISCLERAL VENOUS PRESSURE
- •REFERENCES
- •Intraocular pressure
- •INSTRUMENTS FOR MEASURING INTRAOCULAR PRESSURE
- •APPLANATION INSTRUMENTS
- •Goldmann tonometer
- •Perkins tonometer
- •Draeger tonometer
- •MacKay-Marg and Tono-Pen™ tonometers
- •Pneumatic tonometer
- •Non-contact tonometer
- •The Ocuton™ tonometer
- •Maklakow tonometer
- •INDENTATION INSTRUMENTS
- •Schiøtz tonometer
- •Electronic Schiøtz tonometer
- •Impact–rebound tonometer
- •Transpalpebral tonometry
- •DYNAMIC CONTOUR TONOMETRY
- •CONTINUOUS MONITORING OF INTRAOCULAR PRESSURE
- •SUMMARY OF TONOMETRY
- •DISTRIBUTION OF INTRAOCULAR PRESSURE IN THE GENERAL POPULATION
- •FACTORS THAT INFLUENCE INTRAOCULAR PRESSURE
- •RACE
- •HEREDITY
- •DIURNAL VARIATION
- •SEASONAL VARIATION
- •CARDIOVASCULAR FACTORS
- •EXERCISE
- •WIND INSTRUMENT PLAYING
- •LIFESTYLE
- •POSTURAL CHANGES
- •NEURAL FACTORS
- •PSYCHIATRIC DISORDERS
- •HORMONAL FACTORS
- •REFRACTIVE ERROR
- •FOODS AND DRUGS
- •MISCELLANEOUS
- •EYE MOVEMENTS
- •EYELID CLOSURE
- •INFLAMMATION
- •SURGERY
- •REFERENCES
- •Gonioscopic anatomy
- •GROSS ANATOMY
- •ANATOMIC FEATURES OF NORMAL EYES
- •GONIOSCOPIC ANATOMY AND MICROSCOPIC INTERPRETATION
- •PUPIL AND IRIS
- •CILIARY BODY, IRIS PROCESSES, AND SYNECHIAE
- •SCLERAL SPUR
- •SCHWALBE’S LINE
- •TRABECULAR MESHWORK AND TRABECULAR PIGMENT BAND
- •GONIOSCOPIC APPEARANCE
- •REFERENCES
- •Methods of gonioscopy
- •DEFINITION
- •METHODS OF GONIOSCOPY
- •EQUIPMENT
- •Goldmann and Zeiss lenses (indirect method)
- •Koeppe lens (direct method)
- •TECHNIQUE
- •Indirect gonioscopic lenses
- •Indentation (compression) gonioscopy
- •Direct gonioscopic lens
- •REFERENCES
- •GRADING OF CHAMBER ANGLE
- •DIAGRAMMING ANGLE WIDTH, SYNECHIAE, AND PIGMENTATION
- •TRABECULAR PIGMENT BAND
- •SPAETH CLASSIFICATION
- •STEP 4: TRABECULAR MESHWORK PIGMENTATION
- •EXAMPLES
- •DIFFICULTIES AND ARTIFACTS IN GONIOSCOPY
- •CLINICAL USEFULNESS OF GONIOSCOPY
- •AID IN DIAGNOSIS OF TYPE OF GLAUCOMA
- •EVALUATION OF SYMPTOMS
- •USE OF DRUGS
- •POSTOPERATIVE EXAMINATIONS
- •CONDITIONS OTHER THAN GLAUCOMA
- •SUMMARY OF IMPORTANT GONIOSCOPIC TECHNIQUES
- •REFERENCES
- •APPENDIX
- •Visual field theory and methods
- •THE NORMAL VISUAL FIELD
- •VISUAL ACUITY VERSUS VISUAL FIELD
- •TERMINOLOGY AND DEFINITIONS
- •THEORY OF VISUAL FIELD TESTING
- •KINETIC PERIMETRY
- •STATIC PERIMETRY
- •THRESHOLD-RELATED TESTING
- •ZONE TESTING
- •SCREENING TESTS
- •OTHER STATIC TESTING TECHNIQUES
- •THE FUTURE OF VISUAL FIELD TESTING
- •COMBINED STATIC AND KINETIC PERIMETRY
- •REFERENCES
- •PATIENT VARIABLES
- •FIXATION
- •RELIABILITY
- •OCULAR VARIABLES
- •PUPIL SIZE
- •MEDIA CLARITY
- •REFRACTIVE CORRECTION
- •TESTING VARIABLES
- •TECHNICIAN
- •BACKGROUND ILLUMINATION
- •STIMULUS SIZE AND INTENSITY
- •STIMULUS EXPOSURE TIME
- •AREA TESTED
- •EQUIPMENT AND TECHNIQUES
- •GENERAL PRINCIPLES
- •TANGENT SCREEN
- •BOWL PERIMETRY
- •Preparing the patient
- •Technique of computerized bowl perimetry
- •REFERENCES
- •Visual field interpretation
- •GLAUCOMATOUS CHANGES IN THE VISUAL FIELD
- •ANATOMY OF VISUAL FIELD DEFECTS
- •TYPES OF VISUAL FIELD LOSS
- •Generalized loss
- •Localized defects (scotomata)
- •GLAUCOMATOUS VISUAL FIELD DEFECTS
- •Generalized depression
- •Irregularity of the visual field
- •Nasal step or depression
- •Temporal step or depression
- •Enlargement of the blind spot
- •Isolated paracentral scotomata
- •Arcuate defects (nerve fiber bundle defects)
- •End-stage defects
- •Central and temporal islands
- •Reversal of visual field defects
- •ANALYSIS OF VISUAL FIELD LOSS
- •CHRONIC OPEN-ANGLE GLAUCOMA
- •ANGLE-CLOSURE GLAUCOMA
- •OTHER CAUSES
- •ESTERMAN DISABILITY RATING
- •ANALYSIS OF COMPUTERIZED STATIC PERIMETRY
- •RELIABILITY INDEXES
- •False-positive and false-negative responses
- •Fixation reliability
- •FLUCTUATION
- •Short-term fluctuation
- •Long-term fluctuation
- •GLOBAL INDEXES
- •Mean sensitivity
- •Mean deviation or defect
- •Standard deviation or variance
- •GRAPHIC PLOTS
- •AREA OF THE VISUAL FIELD TO BE TESTED
- •LONG-TERM ANALYSIS
- •DETERMINATION OF NORMAL VISUAL FIELD
- •DEVIATION FROM NORMAL VALUES
- •Graphic plot of points varying from normal
- •Global indexes
- •Comparison with the other eye
- •Localized variation within the visual field
- •RECOGNITION OF CHANGE
- •QUANTIFYING VISUAL FIELD CHANGE
- •THE FUTURE OF COMPUTERIZED PERIMETRY
- •REFERENCES
- •Other psychophysical tests
- •INTRODUCTION
- •COLOR VISION AND SHORT-WAVELENGTH AUTOMATED PERIMETRY
- •FREQUENCY-DOUBLING PERIMETRY
- •OTHER PSYCHOPHYSICAL TESTS
- •HIGH-PASS RESOLUTION PERIMETRY
- •MOTION DETECTION PERIMETRY
- •ELECTROPHYSIOLOGY
- •The electroretinogram (ERG)
- •The pattern electroretinogram (PERG)
- •The multifocal electroretinogram (mfERG)
- •The multifocal visual-evoked potential (mfVEP)
- •REFERENCES
- •ANATOMY OF THE OPTIC NERVE HEAD
- •WHERE ARE THE GANGLION CELLS INJURED?
- •WHAT INJURES GANGLION CELLS?
- •Ganglion Cell Susceptibility
- •Connective tissue structures within the optic nerve head
- •Vascular nutrition of the optic disc
- •REFERENCES
- •CLINICAL TECHNIQUES OF EVALUATION
- •OPTIC DISC CHANGES IN GLAUCOMA
- •INTRAPAPILLARY DISC CHANGES
- •Optic disc size
- •Optic disc shape
- •Neuroretinal rim size (NRR)
- •Neuroretinal rim shape
- •Optic cup size in relation to optic disc size
- •Optic cup configuration and depth
- •Cup:disc ratios
- •Position of central retinal vessels and branches
- •PERIPAPILLARY DISC CHANGES
- •Optic disc hemorrhages
- •Nerve fiber layer defects
- •Diameter of retinal arterioles
- •Peripapillary choroidal atrophy
- •PATTERNS OF OPTIC NERVE CHANGES AND SUBTYPES OF GLAUCOMA
- •HIGH MYOPIA DISC PATTERN
- •FOCAL NORMAL-PRESSURE PATTERN (FOCAL ISCHEMIC)
- •AGE-RELATED ATROPHIC PRIMARY OPEN-ANGLE GLAUCOMA PATTERN (SENILE SCLEROTIC)
- •JUVENILE OPEN-ANGLE GLAUCOMA PATTERN
- •PRIMARY OPEN-ANGLE GLAUCOMA PATTERN (GENERALIZED ENLARGEMENT)
- •REFERENCES
- •Optic nerve imaging
- •CONFOCAL SCANNING LASER OPHTHALMOSCOPY (CSLO)
- •HEIDELBERG RETINA TOMOGRAPHY (HRT)
- •Components of the HRT report
- •Evaluating scan quality
- •Strengths and limitations
- •New developments
- •Testing from the patient’s perspective
- •OPTICAL COHERENCE TOMOGRAPHY (OCT)
- •DIFFERENT SCANNING MODALITIES
- •Peripapillary scan
- •Macular scan
- •ONH scan
- •Fast scans
- •COMPONENTS OF THE OCT REPORT
- •RNFL thickness average analysis
- •Macular analysis
- •Optic nerve head analysis
- •QUALITY ASSESSMENT
- •STRENGTHS AND LIMITATIONS
- •TESTING FROM THE PATIENT’S PERSPECTIVE
- •LONGITUDINAL EVALUATIONS
- •SCANNING LASER POLARIMETRY
- •Components of the GDX report
- •Quality assessment
- •Strengths and limitations
- •Testing from the patient’s perspective
- •CONCLUSIONS
- •REFERENCES
- •Primary angle-closure glaucoma
- •HISTORICAL REVIEW AND CLASSIFICATIONS
- •CLASSIFICATIONS OF ANGLE-CLOSURE DISEASE
- •TWENTY-FIRST CENTURY CONSENSUS CLASSIFICATION
- •CLARIFICATIONS AND COMMENTARY
- •PRESENTATIONS OF PRIMARY ANGLE-CLOSURE DISEASE
- •NEW IMAGING TECHNOLOGIES
- •CLASSIFICATION BY MECHANISMS IN THE ANTERIOR SEGMENT
- •PUPILLARY BLOCK GLAUCOMA
- •Epidemiologic studies
- •Demographic risk factors
- •Gender
- •Heredity
- •Refractive error
- •Miscellaneous factors
- •Ocular risk factors and mechanisms
- •Iris bowing and lens–iris channel
- •Provocative tests
- •Clinical presentations of acute PACG with pupillary block
- •Signs and symptoms
- •Clinical examination
- •Treatment of acute PACG
- •Medical management of acute PACG
- •Slit-lamp maneuvers in management of acute PACG
- •Laser interventions for acute PACG
- •Surgical management of PACG
- •Management of the fellow eye
- •Sequelae of acute PACG
- •Correlating older and newer terminologies for angle closure
- •PLATEAU IRIS
- •Plateau iris configuration
- •Plateau iris syndrome
- •Pseudoplateau iris (cysts of the iris and ciliary body)
- •PHACOMORPHIC GLAUCOMA
- •Intumescent and swollen lens
- •REFERENCES
- •OVERVIEW OF TERMS AND MECHANISMS
- •ANTERIOR PULLING MECHANISM
- •NEOVASCULAR GLAUCOMA
- •Histopathology
- •Pathogenesis
- •Conditions and diseases commonly associated with neovascular glaucoma
- •Diabetes mellitus
- •Central retinal vein occlusion
- •Carotid occlusive disease
- •Ocular ischemic syndrome
- •Central retinal artery occlusion
- •Miscellaneous
- •Clinical presentation
- •Treatment
- •IRIDOCORNEAL ENDOTHELIAL SYNDROME
- •Histopathology
- •Pathogenesis
- •Clinical presentation
- •Progressive (essential) iris atrophy
- •Chandler’s syndrome
- •Cogan-Reese syndrome
- •Treatment
- •POSTERIOR POLYMORPHOUS DYSTROPHY
- •Histopathology
- •Pathogenesis
- •Clinical presentation
- •Treatment
- •EPITHELIAL DOWNGROWTH
- •Pathophysiology
- •Histopathology
- •Clinical presentation
- •Treatment
- •FIBROVASCULAR INGROWTH
- •FLAT ANTERIOR CHAMBER
- •INFLAMMATION
- •PENETRATING KERATOPLASTY
- •IRIDOSCHISIS
- •ANIRIDIA
- •POSTERIOR PUSHING (OR ROTATIONAL) MECHANISM
- •CILIARY BLOCK GLAUCOMA (AQUEOUS MISDIRECTION OR MALIGNANT GLAUCOMA)
- •INTRAOCULAR TUMORS
- •NANOPHTHALMOS
- •SUPRACHOROIDAL HEMORRHAGE
- •POSTERIOR SEGMENT INFLAMMATORY DISEASE
- •Treatment
- •CENTRAL RETINAL VEIN OCCLUSION
- •SCLERAL BUCKLING PROCEDURE
- •PANRETINAL PHOTOCOAGULATION
- •RETINOPATHY OF PREMATURITY
- •PUPILLARY BLOCK MECHANISMS
- •Secondary pupillary block glaucoma: iris–lens adhesions
- •Dislocated and subluxed lens
- •Ectopia lentis
- •Microspherophakia
- •REFERENCES
- •Primary open angle glaucoma
- •EPIDEMIOLOGY
- •PREVALENCE
- •PATHOPHYSIOLOGY
- •DIMINISHED AQUEOUS HUMOR OUTFLOW FACILITY
- •Altered corticosteroid metabolism
- •Dysfunctional adrenergic control
- •Abnormal immunologic processes
- •Oxidative damage
- •Other toxic influences
- •OPTIC NERVE CUPPING AND ATROPHY
- •CLINICAL FEATURES
- •FINDINGS
- •DIFFERENTIAL DIAGNOSIS
- •TREATMENT
- •INDICATIONS
- •GOALS
- •Target pressure
- •TYPES OF TREATMENT
- •PROGNOSIS
- •THE GLAUCOMA SUSPECT AND OCULAR HYPERTENSION
- •EPIDEMIOLOGY OF OCULAR HYPERTENSION
- •RISK FACTORS FOR DEVELOPMENT OF OPEN-ANGLE GLAUCOMA
- •TREATMENT
- •NORMAL-TENSION GLAUCOMA
- •PATHOGENESIS
- •CLINICAL FEATURES
- •DIFFERENTIAL DIAGNOSIS
- •WORK-UP
- •TREATMENT
- •REFERENCES
- •Secondary open angle glaucoma
- •PIGMENTARY GLAUCOMA
- •EXFOLIATION SYNDROME (PSEUDOEXFOLIATION SYNDROME)
- •CORTICOSTEROID GLAUCOMA
- •LENS-INDUCED GLAUCOMA
- •PHACOLYTIC GLAUCOMA
- •LENS-PARTICLE GLAUCOMA
- •PHACOANAPHYLAXIS
- •GLAUCOMA AFTER CATARACT SURGERY
- •GLAUCOMA FROM VISCOELASTIC SUBSTANCES
- •GLAUCOMA WITH PIGMENT DISPERSION FROM INTRAOCULAR LENSES
- •UVEITIS-GLAUCOMA-HYPHEMA SYNDROME
- •GLAUCOMA FROM VITREOUS IN THE ANTERIOR CHAMBER
- •GLAUCOMA AFTER TRAUMA
- •CHEMICAL BURNS
- •ELECTRIC SHOCK
- •RADIATION
- •PENETRATING INJURIES
- •CONTUSION INJURIES
- •GLAUCOMA ASSOCIATED WITH INTRAOCULAR HEMORRHAGE
- •GHOST-CELL GLAUCOMA
- •HEMOLYTIC GLAUCOMA
- •HEMOSIDEROSIS
- •HYPHEMA
- •RETINAL DETACHMENT AND GLAUCOMA
- •SCHWARTZ SYNDROME
- •GLAUCOMA AFTER VITRECTOMY
- •GLAUCOMA WITH UVEITIS
- •FUCHS’ HETEROCHROMIC IRIDOCYCLITIS
- •GLAUCOMATOCYCLITIC CRISIS
- •HERPES SIMPLEX
- •HERPES ZOSTER
- •SARCOIDOSIS
- •JUVENILE RHEUMATOID ARTHRITIS
- •SYPHILIS
- •INTRAOCULAR TUMORS AND GLAUCOMA
- •AMYLOIDOSIS
- •ELEVATED EPISCLERAL VENOUS PRESSURE
- •SUPERIOR VENA CAVA OBSTRUCTIONS
- •THYROID EYE DISEASE
- •ARTERIOVENOUS FISTULAS
- •STURGE-WEBER SYNDROME
- •IDIOPATHIC ELEVATIONS
- •REFERENCES
- •TERMINOLOGY
- •CLASSIFICATION
- •SYNDROME CLASSIFICATION
- •PRIMARY GLAUCOMA
- •CLINICAL ANATOMIC CLASSIFICATION
- •Isolated trabeculodysgenesis
- •Iridodysgenesis
- •Anterior stromal defects
- •Structural iris defects
- •Corneodysgenesis
- •CLINICAL PRESENTATION
- •EXAMINATION
- •Office examination
- •Examination under anesthesia
- •Intraocular pressure measurement
- •Corneal measurements: diameter and central thickness
- •Axial length measurement
- •Gonioscopy
- •Ophthalmoscopy
- •Cycloplegic refraction
- •Systemic evaluation
- •PRIMARY CONGENITAL GLAUCOMA
- •INCIDENCE
- •GENETICS AND HEREDITY
- •PATHOPHYSIOLOGY
- •DIFFERENTIAL DIAGNOSIS
- •Other glaucomas
- •Other causes of corneal enlargement or clouding
- •Other causes of epiphora or photophobia
- •Other optic nerve abnormalities
- •MANAGEMENT
- •Preoperative management
- •Initial surgery
- •Follow-up evaluations
- •Filtering surgery
- •Synthetic drainage devices
- •Cyclodestructive procedures
- •Long-term follow-up, management, and prognosis
- •Late developing primary congenital glaucoma
- •GLAUCOMA ASSOCIATED WITH OTHER CONGENITAL ANOMALIES
- •FAMILIAL HYPOPLASIA OF THE IRIS WITH GLAUCOMA
- •DEVELOPMENTAL GLAUCOMA WITH ANOMALOUS SUPERFICIAL IRIS VESSELS
- •ANIRIDIA
- •STURGE-WEBER SYNDROME (ENCEPHALOFACIAL ANGIOMATOSIS, ENCEPHALOTRIGEMINAL ANGIOMATOSIS)
- •NEUROFIBROMATOSIS (VON RECKLINGHAUSEN’S DISEASE)
- •PIERRE ROBIN AND STICKLER SYNDROMES
- •SKELETAL DYSPLASTIC SYNDROMES
- •CORNEODYSGENESIS
- •Axenfeld’s anomaly
- •Rieger’s anomaly and syndrome
- •PETER’S ANOMALY
- •LOWE SYNDROME (OCULOCEREBRORENAL SYNDROME)
- •MICROCORNEA SYNDROMES
- •RUBELLA
- •CHROMOSOME ABNORMALITIES
- •BROAD THUMB SYNDROME (RUBENSTEIN–TAYBI SYNDROME)
- •SECONDARY GLAUCOMA IN INFANTS
- •PERSISTENT FETAL VASCULATURE (PERSISTENT HYPERPLASITIC PRIMARY VITREOUS)
- •RETINOPATHY OF PREMATURITY (RETROLENTAL FIBROPLASIAS)
- •LENS-RELATED GLAUCOMAS
- •Aphakic pediatric glaucoma
- •Subluxation and pupillary block
- •Marfan syndrome
- •Homocystinuria
- •Spherophakia and pupillary block
- •Weill-Marchesani and GEMSS syndromes
- •TUMORS
- •Retinoblastoma
- •Juvenile xanthogranuloma
- •INFLAMMATION
- •Juvenile rheumatoid arthritis
- •STEROID GLAUCOMA IN CHILDREN
- •NEOVASCULAR GLAUCOMA
- •TRAUMA
- •REFERENCES
- •Genetics of glaucoma
- •BASIC GENETICS
- •GENETIC NOMENCLATURE
- •PRIMARY OPEN-ANGLE, NORMAL-TENSION, AND JUVENILE-ONSET OPEN-ANGLE GLAUCOMA
- •TIGR/MYOCILIN
- •OPTINEURIN
- •OTHER GENES IN OPEN-ANGLE GLAUCOMA
- •EXFOLIATION SYNDROME AND GLAUCOMA
- •GLAUCOMA ASSOCIATED WITH DEVELOPMENTAL DISORDERS
- •PRIMARY CONGENITAL GLAUCOMA
- •AXENFELD-RIEGER ANOMALY
- •ANIRIDIA
- •NAIL PATELLA SYNDROME
- •RENAL TUBULAR ACIDOSIS
- •SUMMARY
- •REFERENCES
- •DIAGNOSIS
- •IDENTIFYING GLAUCOMA SUSPECTS
- •DETERMINING ADEQUACY OF TREATMENT
- •TREATMENT FOLLOW-UP
- •DOCUMENTATION OF PROGRESS
- •PATIENT EDUCATION
- •EFFECTIVE JUDGMENT
- •REFERENCES
- •TARGET PRESSURE
- •MEDICAL THERAPY
- •ADVANTAGES
- •DISADVANTAGES
- •SURGICAL THERAPY
- •ADVANTAGES
- •DISADVANTAGES
- •BASIC PHARMACOLOGY
- •BIOAVAILABILITY OF TOPICAL OCULAR MEDICATION
- •TEAR FILM
- •CORNEAL BARRIERS
- •DRUG FORMULATION
- •DRUG ELIMINATION
- •COMPLIANCE
- •GENERAL SUGGESTIONS FOR MEDICAL TREATMENT OF GLAUCOMA
- •ESTABLISH A TARGET PRESSURE
- •ADJUST THE TREATMENT PROGRAM TO THE PATIENT AND HIS OR HER LIFESTYLE
- •WHEN THERAPY IS INEFFECTIVE, SUBSTITUTE RATHER THAN ADD DRUGS
- •CONTINUALLY MONITOR THE TARGET PRESSURE
- •ASK ABOUT AND MONITOR OCULAR AND SYSTEMIC SIDE EFFECTS
- •SIMPLIFY AND REDUCE TREATMENT WHEN POSSIBLE
- •TEACH PATIENTS THE PROPER TECHNIQUE FOR INSTILLING EYEDROPS
- •PROVIDE WRITTEN INSTRUCTIONS
- •COMMUNICATE WITH THE PATIENT’S FAMILY PHYSICIAN
- •ASK ABOUT PROBLEMS WITH THE MEDICAL REGIMEN
- •CONSIDER DEFAULTING AS AN EXPLANATION FOR THE FAILURE OF MEDICAL TREATMENT
- •EDUCATE PATIENTS ABOUT THEIR ILLNESS AND ITS TREATMENT
- •STOP TREATMENT PERIODICALLY TO DETERMINE CONTINUING EFFECTIVENESS
- •MEASURE INTRAOCULAR PRESSURE AT DIFFERENT TIMES OF THE DAY AND AT DIFFERENT INTERVALS AFTER THE LAST ADMINISTRATION OF MEDICATION
- •RECOMMEND COMPARISON SHOPPING FOR MEDICATIONS
- •SUMMARY
- •REFERENCES
- •Prostaglandins
- •MECHANISM OF ACTION
- •DRUGS IN CLINICAL USE
- •LATANOPROST (XALATAN, PHXA41)
- •BIMATOPROST
- •TRAVOPROST
- •FIXED COMBINATION AGENTS
- •SIDE EFFECTS
- •SUGGESTIONS FOR USE
- •REFERENCES
- •MECHANISM(S) OF ACTION
- •EPINEPHRINE
- •DIPIVEFRIN
- •NOREPINEPHRINE
- •Phenylephrine
- •Clonidine
- •Apraclonidine
- •Brimonidine
- •Isoproterenol
- •Salbutamol
- •Others
- •DOPAMINERGIC AGONISTS
- •ADRENERGIC POTENTIATORS
- •MONOAMINE OXIDASE AND CATECHOL O-METHYLTRANSFERASE INHIBITORS
- •6-HYDROXYDOPAMINE
- •PROTRIPTYLINE
- •GUANETHIDINE (ISMELIN)
- •NONADRENERGIC ACTIVATORS OF ADENYLATE CYCLASE
- •DRUGS IN CLINICAL USE
- •Epinephrine (Eppy, Epinal, Epifrin, and generics)
- •Dipivefrin (Propine and generics)
- •Suggestions for use
- •Side effects
- •Clonidine
- •Prophylaxis in anterior segment laser surgery
- •Argon laser trabeculoplasty
- •Laser iridotomy
- •Nd:YAG laser posterior capsulotomy
- •Management of acute pressure rises
- •Management of open-angle and other chronic glaucomas
- •Combination therapy
- •Side effects
- •Suggestions for use
- •SUMMARY
- •REFERENCES
- •Adrenergic antagonists
- •MECHANISM OF ACTION
- •DRUGS IN CLINICAL USE
- •TIMOLOL MALEATE
- •TIMOLOL HEMIHYDRATE
- •BETAXOLOL
- •LEVOBUNOLOL
- •CARTEOLOL
- •METIPRANOLOL
- •PROPRANOLOL
- •ATENOLOL
- •PINDOLOL
- •NADOLOL
- •METAPROLOL
- •LABETOLOL
- •SUGGESTIONS FOR USE
- •OPEN-ANGLE GLAUCOMA
- •ANGLE-CLOSURE GLAUCOMA
- •SECONDARY GLAUCOMA
- •GLAUCOMA IN CHILDREN
- •BLOOD FLOW AND NEUROPROTECTION
- •SIDE EFFECTS
- •OCULAR
- •SYSTEMIC
- •OTHER ADRENERGIC ANTAGONISTS
- •Thymoxamine
- •Dapiprazole
- •Bunazosin
- •Prazosin
- •Others
- •REFERENCES
- •Carbonic anhydrase inhibitors
- •MECHANISM OF ACTION
- •DIRECT EFFECT ON AQUEOUS HUMOR FORMATION
- •INDIRECT EFFECT ON AQUEOUS HUMOR FORMATION
- •DRUGS IN CLINICAL USE
- •TOPICAL CARBONIC ANHYDRASE INHIBITORS
- •Dorzolamide
- •Brinzolamide
- •SYSTEMIC CARBONIC ANHYDRASE INHIBITORS
- •Acetazolamide
- •Methazolamide
- •Ethoxzolamide
- •Dichlorphenamide
- •SIDE EFFECTS
- •TOPICAL CARBONIC ANHYDRASE INHIBITORS
- •ORAL CARBONIC ANHYDRASE INHIBITORS
- •CONTRAINDICATIONS
- •Acidosis and sickling of red blood cells
- •Other severe symptoms
- •Retinal-choroidal blood flow and neuroprotection
- •SUGGESTIONS FOR USE
- •ANGLE-CLOSURE GLAUCOMA
- •OPEN-ANGLE GLAUCOMA
- •SECONDARY GLAUCOMA
- •INFANTILE AND JUVENILE GLAUCOMA
- •OTHER USES
- •REFERENCES
- •Cholinergic drugs
- •MECHANISMS OF ACTION
- •ANGLE-CLOSURE GLAUCOMA
- •OPEN-ANGLE GLAUCOMA
- •DRUGS IN CLINICAL USE
- •DIRECT-ACTING CHOLINERGIC AGENTS
- •Acetylcholine
- •Pilocarpine
- •Alternative drug delivery systems
- •Methacholine (Mecholyl)
- •Carbachol
- •Aceclidine (Glaucostat)
- •INDIRECT (ANTICHOLINESTERASE) AGENTS
- •Echothiophate iodide (phospholine iodide)
- •Demecarium bromide (Humorsol, Tosmilen)
- •Isoflurophate (Floropryl, di-isopropyl fluorophosphate, Dyflos)
- •Physostigmine (eserine)
- •Neostigmine (prostigmine)
- •SIDE EFFECTS
- •OCULAR
- •SYSTEMIC
- •SUGGESTIONS FOR USE
- •EXAMINATION
- •CONTRAINDICATIONS
- •REFERENCES
- •Hyperosmotic agents
- •MECHANISMS OF ACTION
- •DRUGS IN CLINICAL USE
- •ORAL AGENTS
- •Glycerol
- •Isosorbide
- •Ethyl alcohol
- •INTRAVENOUS AGENTS
- •Mannitol
- •Urea
- •SIDE EFFECTS
- •SUGGESTIONS FOR CLINICAL USE
- •ANGLE-CLOSURE GLAUCOMA
- •SECONDARY GLAUCOMA
- •CILIARY BLOCK (MALIGNANT) GLAUCOMA
- •TOPICAL HYPEROSMOTIC AGENTS
- •OTHER
- •REFERENCES
- •General aspects of laser therapy
- •GENERAL ASPECTS OF LASER THERAPY
- •TISSUE EFFECTS OF LASER
- •THERMAL EFFECTS (PHOTOCOAGULATION, PHOTOVAPORIZATION)
- •PHOTODISRUPTION
- •PHOTOABLATION
- •PHOTOCHEMICAL EFFECTS
- •GENERAL PREPARATION OF THE PATIENT
- •BASIC LASER SAFETY
- •REFERENCES
- •LASER PERIPHERAL IRIDOTOMY
- •INDICATIONS
- •TYPES OF LASER
- •GENERAL PREPARATION
- •ND:YAG LASER IRIDOTOMY
- •ARGON OR SOLID-STATE LASER IRIDOTOMY
- •LIGHT BROWN IRIS
- •Dark brown iris
- •Light blue iris
- •COMPLICATIONS OF LASER IRIDOTOMY
- •Iritis
- •Pressure elevation
- •Cataract
- •Hyphema
- •Corneal epithelial injury
- •Endothelial damage
- •Corneal stroma
- •Failure to perforate
- •Late closure
- •Retinal burn
- •Aphakia and pseudophakia with pupillary block
- •LASER IRIDOPLASTY (GONIOPLASTY)
- •PLATEAU IRIS
- •NANOPHTHALMOS
- •LASERS IN MALIGNANT GLAUCOMA
- •REFERENCES
- •LASER TRABECULOPLASTY
- •HISTORY
- •RESULTS
- •SELECTIVE LASER TRABECULOPLASTY
- •Concept
- •Mechanism
- •Technique
- •Patient preparation
- •Procedure
- •POSTOPERATIVE TREATMENT
- •OUTCOMES
- •CONTRAINDICATIONS
- •AS INITIAL THERAPY
- •PREDICTORS OF OUTCOME
- •APHAKIC AND PSEUDOPHAKIC OPEN-ANGLE GLAUCOMA
- •COMPLICATIONS
- •Intraocular pressure elevation
- •Sustained intraocular pressure increase
- •Hyphema
- •Peripheral anterior synechiae
- •Iritis
- •Uveitis
- •EXCIMER LASER TRABECULOSTOMY
- •Concept
- •Technique
- •Outcomes
- •OTHER LASER SCLEROSTOMY TECHNIQUES
- •REFERENCES
- •CYCLOPHOTOCOAGULATION
- •OTHER LASER PROCEDURES
- •SEVERING OF SUTURES
- •REOPENING FAILED FILTRATION SITES
- •CYCLODIALYSIS AND LASER
- •LASER SYNECHIALYSIS
- •GONIOPHOTOCOAGULATION
- •PHOTOMYDRIASIS (PUPILLOPLASTY)
- •REFERENCES
- •General surgical care
- •THE SURGICAL DECISION
- •PREOPERATIVE CARE
- •INSTRUCTIONS TO THE PATIENT
- •OUTPATIENT VERSUS INPATIENT SURGERY
- •PREOPERATIVE MEDICATIONS
- •OPERATIVE CARE
- •THE OPERATING ROOM
- •ANESTHESIA
- •EQUIPMENT
- •POSTOPERATIVE CARE
- •ACTIVITY
- •MEDICATIONS
- •REFERENCES
- •Glaucoma outflow procedures
- •GENERAL CONSIDERATIONS
- •EXTERNAL FILTRATION SURGERY
- •GUARDED PROCEDURES
- •FULL-THICKNESS PROCEDURES
- •RESULTS OF EXTERNAL FILTRATION SURGERY
- •THE CONJUNCTIVAL FLAP
- •LIMBUS-BASED FLAP
- •FORNIX-BASED FLAP
- •EXCISION OF TENON’S CAPSULE
- •GUARDED FILTRATION PROCEDURE
- •TRABECULECTOMY
- •Indications
- •Standard technique
- •Moorfields Safer Surgery System technique
- •Results
- •Surgical options and modifications
- •Triangular versus rectangular flap
- •Postoperative lasering, adjustment, or release of sutures
- •Wound-healing retardants
- •FULL-THICKNESS FILTRATION PROCEDURES
- •THERMAL SCLEROSTOMY (SCHEIE PROCEDURE)
- •SCLERECTOMY
- •Posterior lip sclerectomy
- •Anterior lip sclerectomy
- •TREPHINATION
- •IRIDENCLEISIS
- •GLAUCOMA DRAINAGE DEVICES
- •THE MOLTENO IMPLANT
- •Techniques
- •SCHOCKET PROCEDURE
- •KRUPIN VALVE AND EX-PRESS IMPLANT
- •AHMED VALVE
- •BAERVELDT IMPLANT
- •RESULTS AND COMPLICATIONS OF DRAINAGE DEVICES
- •REFERENCES
- •CATARACT SURGERY IN THE GLAUCOMATOUS EYE
- •TYPES OF GLAUCOMA AND THEIR INFLUENCE ON CATARACT MANAGEMENT
- •SELECTING THE APPROPRIATE SURGICAL APPROACH
- •SELECTING THE APPROPRIATE PROCEDURE: HISTORICAL CONSIDERATIONS
- •SURGICAL TECHNIQUES FOR COMBINED PROCEDURES
- •GENERAL PREOPERATIVE CONSIDERATIONS
- •SMALL-INCISION COMBINED SURGERY
- •Incision sites
- •Fornix versus limbal conjunctival flap
- •Scleral flap
- •Antimetabolite use
- •Managing the small pupil
- •Phacoemulsification techniques
- •Intraocular lens selection
- •Trabeculectomy formation
- •Flap closure
- •Postoperative medical management
- •EXTRACAPSULAR CATARACT EXTRACTION COMBINED SURGERY
- •Miotic pupil
- •Incision construction
- •CATARACT SURGERY WITH PRE-EXISTING FILTRATION BLEB
- •REFERENCES
- •BUTTONHOLING THE CONJUNCTIVA
- •THE SHALLOW AND FLAT ANTERIOR CHAMBER
- •FLAT ANTERIOR CHAMBER WITH HYPOTONY
- •FLAT ANTERIOR CHAMBER IN NORMOTENSIVE AND HYPERTENSIVE EYES
- •CILIARY BLOCK (MALIGNANT GLAUCOMA)
- •SUPRACHOROIDAL HEMORRHAGE (SCH)
- •INTRAOPERATIVE FLAT ANTERIOR CHAMBER
- •HYPHEMA
- •LARGE HYPHEMA
- •INTRAOCULAR INFECTION
- •SYMPATHETIC OPHTHALMIA
- •FILTRATION FAILURE
- •DIGITAL PRESSURE
- •FAILURE DURING THE FIRST POSTOPERATIVE WEEK
- •PLUGGED SCLEROSTOMY SITE
- •RETAINED VISCOELASTIC MATERIAL
- •TIGHT SCLERAL FLAP: RELEASABLE SUTURES AND LASER SUTURE LYSIS
- •INADEQUATE OPENING OF DESCEMET’S MEMBRANE
- •ENCAPSULATED BLEB
- •REOPERATION AFTER FAILED FILTRATION
- •REVISION OF ENCYSTED BLEB
- •Needling of failed blebs
- •Slit-lamp or minor surgery setting
- •Operating room setting
- •FAILED FILTRATION WITH NO BLEB
- •BLEB COMPLICATIONS AND MANAGEMENT
- •THIN-WALLED BLEBS
- •DIFFUSE BLEBS
- •OVERFUNCTIONING BLEBS
- •DELLEN
- •HYPOTONOUS MACULOPATHY
- •LATE HYPOTONY AFTER FILTERING SURGERY
- •HYPOTONY WITH OCCULT FILTERING ‘BLEB’
- •HYPOTONY WITH OCCULT CYCLODIALYSIS CLEFTS
- •HYPOTONY WITH AQUEOUS SUPPRESSION THERAPY IN CONTRALATERAL EYE
- •HYPOTONY FROM RETINAL DETACHMENT
- •HYPOTONY FROM IRITIS OR ISCHEMIA
- •REFERENCES
- •SURGERY FOR INFANTILE AND JUVENILE GLAUCOMA
- •GONIOTOMY
- •Preoperative considerations
- •Intraoperative procedures
- •Complications
- •Practice goniotomy
- •Other ab-interno angle surgery
- •TRABECULOTOMY AB EXTERNO
- •EVALUATION OF GONIOTOMY AND TRABECULOTOMY
- •COMBINED TRABECULOTOMY AND TRABECULECTOMY
- •TRABECULODIALYSIS
- •MISCELLANEOUS PROCEDURES
- •Goniosynechialysis
- •Cyclocryotherapy
- •Retrobulbar alcohol injection
- •Earlier procedures
- •REFERENCES
- •New ideas in glaucoma surgery
- •INTRODUCTION
- •NON-PENETRATING GLAUCOMA SURGERY
- •VISCOCANALOSTOMY
- •BYPASS INTRASCLERAL CHANNELS (NON-PENETRATING DEEP SCLERECTOMY)
- •SHUNTS INTO SCHLEMM’S CANAL
- •TRABECTOME®
- •SHUNTS INTO THE SUPRACHOROIDAL SPACE
- •SUMMARY
- •REFERENCES
- •Challenges for the new century
- •PATHOPHYSIOLOGY
- •CLASSIFICATION AND DIAGNOSIS
- •SCREENING
- •TREATMENT
- •CONCLUSION
- •REFERENCES
- •Appendix
- •GLAUCOMA CONSENSUS
- •GLAUCOMA DIAGNOSIS – STRUCTURE AND FUNCTION (2004)
- •CONSENSUS STATEMENTS
- •Structure
- •Function
- •Function and structure
- •GLAUCOMA SURGERY – OPEN ANGLE GLAUCOMA (2005)
- •CONSENSUS STATEMENTS
- •Indications for glaucoma surgery
- •Argon laser trabeculoplasty
- •Wound healing
- •Trabeculectomy
- •Combined cataract/trabeculectomy
- •Aqueous shunting procedures with glaucoma drainage devices
- •Comparison of procedures: trabeculectomy versus aqueous shunting procedures with glaucoma drainage devices
- •Non-penetrating glaucoma drainage surgery
- •Comparison of trabeculectomy with non-penetrating drainage glaucoma surgery in open-angle glaucoma
- •Cyclodestruction
- •Comparison of cyclophotocoagulation and glaucoma drainage device implantation
- •ANGLE CLOSURE AND ANGLE-CLOSURE GLAUCOMA (2006)
- •CONSENSUS STATEMENTS
- •Management of acute angle closure crisis
- •Surgical management of primary angle-closure glaucoma
- •Laser and medical treatment of primary angle-closure glaucoma
- •Laser and medical treatment of primary angle-closure glaucoma
- •Detection of primary angle closure and angle-closure glaucoma
- •INTRAOCULAR PRESSURE (2007)
- •CONSENSUS STATEMENTS
- •Measurement of intraocular pressure
- •Intraocular pressure as a risk factor for glaucoma development & progression
- •Epidemiology of intraocular pressure
- •Clinical trials and intraocular pressure
- •Target intraocular pressure in clinical practice
- •Index
part 4 clinical entities
17 |
Primary open angle glaucoma |
CHAPTER |
|
|
|
Primary open-angle glaucoma (POAG) can be considered a chronic, progressive, anterior optic neuropathy that is accompanied by a characteristic cupping and atrophy of the optic disc, visual field loss, open angles, and no obvious causative ocular or systemic conditions. In the majority, but by no means all, cases the intraocular pressure (IOP) is elevated above the statistically ‘normal’ range, reflecting a reduced aqueous humor outflow facility. Although elevated IOP is not the cause of all damage in POAG, it is the major risk factor.The issue of IOP has been complicated by the rediscovery of the importance of corneal thickness as both a parameter that may cause inaccurate readings with applanation tonometry and an independent factor that may change the risk of developing open angle glaucoma.1 The mechanism by which elevated IOP damages the optic nerve is not clear, but ischemia of the optic disc or nerve fiber layer, direct mechanical compression of axons, local toxicity, or some combination of these has been implicated.
Primary open-angle glaucoma may be more than one disease with a final common pathway of damage to the ganglion cells and optic nerve; at present, we are unable to clearly distinguish any subclassification, although attempts have been made to divide POAG into ‘IOP sensitive’ and ‘IOP insensitive’ forms. Given our lack of knowledge on this subject, we will continue to discuss POAG as if it were a single disease. Primary open-angle glaucoma is referred to by a variety of other names, including open-angle glaucoma, chronic open-angle glaucoma, chronic simple glaucoma, and openangle glaucoma with damage.
Primary open-angle glaucoma is the most common form of glaucoma in many countries and accounts for 60–70% of the cases seen in the United States. By the year 2000, it was estimated that there were approximately 2.5 million cases of POAG in the United States (about 1.9 million white Americans and 0.6 million black Americans).2 The Dana Center in Baltimore estimates that 45 million people worldwide will have open-angle glaucoma by the year 2010, of which 4.5 million will be bilaterally blind.3 This disease has a hereditary component and becomes more prevalent with age. Because POAG is very slowly progressive, it is usually asymptomatic until late in its course; affected individuals can develop severe damage before they seek professional help. Most cases of POAG are discovered through screening programs or on routine ocular examinations.4,5Population-based screening programs may have a small yield and may not be cost effective; however, screening programs directed towards those at higher risk (e.g. the elderly, people of African descent) may be more productive.6
In a minority of white patients but a majority of Japanese patients, optic nerve cupping and visual field loss develop without recorded IOPs above the statistical norm. This condition is called normaltension glaucoma (normal-pressure glaucoma, low-tension glaucoma,
or low-pressure glaucoma). Many individuals have IOPs above the statistically ‘normal’ range ( 2 standard deviations from the mean, or 21 mmHg), but only a very small percentage of these ever develop optic nerve damage.Those individuals with ‘elevated’ IOPs who also have normal optic nerves, normal visual fields, and no known ocular or systemic condition accounting for the increased pressure are said to have ocular hypertension.These individuals are at increased risk (compared with those with ‘normal’ IOP) of developing true glaucoma. The Ocular Hypertension Treatment Study (OHTS) showed that many of those with above ‘normal’ IOP have thick corneas and are at low risk for development of actual glaucoma.7
The existence of normal-tension glaucoma and ocular hypertension implies that some optic nerves are quite sensitive to the effects of IOP, whereas others are quite resistant. As noted previously, ischemia, mechanical factors, and neurotoxic agents have been cited, but, unfortunately, we are unable to formally identify those clinical factors leading to optic nerve damage. Although we know about some risk factors, it is impossible to determine with any degree of confidence which of those individuals with ‘elevated’ IOPs will ultimately develop actual optic nerve damage (although we can estimate risk). Nor can we determine the ‘safe’ level of IOP for any given individual.
Epidemiology
The study of epidemiology (the distribution of a disease in a population, and the identifiable conditions that are associated with it) helps us understand some of the factors that alter the risk of glaucoma, its progression, and its sequelae.The understanding of POAG has been significantly improved in recent years by the application of epidemiologic principles. From reviews of various sources of data, it can be estimated that 2.25 million Americans 40 years of age and older have POAG.8 In Australia, the prevalence of definite glaucoma ranges from 2.1 to 2.5% of those over 50 years old and the number of people with glaucoma is expected to double by the year 2030.9 Worldwide, over 2 million people develop this condition every year. Between 84 000 and 116 000 persons are estimated to be bilaterally blind (visual acuity 20/200) in the United States.Worldwide, more than 3 million people are bilaterally blind because of POAG.10
Prevalence
In most studies performed in western Europe and in the United States, the prevalence of POAG11 is 0.5–1% of the population
239
part
4 CLINICAL ENTITIES
above age 40 (Table 17-1).Various studies have reported different prevalences depending on the population sampled, the ages of the individuals studied, the techniques of examination, and the definitions of glaucoma used. The most recent US study using rigorous definitions estimated the overall prevalence of open-angle glaucoma at about 1.9% of those over 40, with blacks having three times the prevalence of whites.27 A similar overall prevalence was found for definite POAG in those over age 40 in Spain.28 Many previous studies found higher prevalence rates because the investigators diagnosed glaucoma by elevated IOP or abnormal aqueous humor dynamics instead of visual field loss and optic disc cupping.
However, even more recent studies, using strict criteria for optic nerve damage, have shown a surprisingly high prevalence, especially among those of black African ancestry and among those over 70 years of age (see Ch. 1). Recent studies have emphasized the differences among various racial and ethnic groups vis-à-vis the prevalence of glaucoma. For example, in southern India, the prevalence of openangle glaucoma is 1.6% of the population with greater than 98% unaware that they have the disease.29 In Japan, glaucoma is quite common compared to other Asian and Caucasian societies. In the Tajima study, 3.9% of those over 40 years old had POAG and the vast majority had IOPs below 21 mmHg.30 Among Singapore Chinese, the prevalence of POAG in those over 40 years of age is about 1.6%.31 The prevalence of open-angle glaucoma also appears to be relatively high in a population study in Bangladesh (about 2% in people over 40).32 However, the highest prevalence is still in those of west African origin; for example, in Ghana, the prevalence of open-angle glaucoma is over 8% in those over 40.33 In South Africa, the prevalence of glaucoma in general was almost 3% among black South Africans over 40; surprisingly, 16% of these had exfoliative glaucoma.34 However, even some Caucasian populations may have a high prevalence of glaucoma; for example, in Iceland, the prevalence of glaucoma (including exfoliative) in those over 50 is 4%.35 In another example, Greeks seem to have an unusually high prevalence: 4% compared to other European groups.36 Australians also have a relatively high prevalence of glaucoma (3%), with women having a higher prevalence than men and the prevalence increasing ‘exponentially’ with age.37
Incidence
Few studies determining the true incidence of POAG in the general population have been undertaken. A study of this type requires a large population-based sample with long-term follow-up. Such a study has been performed in Barbados over 4 years. In this population of largely black African ancestry, the 4-year incidence of glaucoma over 40 years of age is 2.2%, with higher rates for males, those of African ancestry, those with high IOPs, and those with suspicious discs at enrollment.38 Incident rates increased from 1.2% in the 40–49 age group to 4.2% in those over 70.39 Using data from the Framingham study, Podgor and co-workers40 have estimated that the incidence of POAG rises from 0.2% at age 55 to 1.1% at age 70; that is, the incidence of POAG is 2 cases per 1000 people per year from age 55 to 60 years, and 11 cases per 1000 people per year from age 70 to 75 years.The Rotterdam study showed that the incidence of glaucoma over 6.5 years in those over 55 years of age was 1.2% for probable open-angle glaucoma and 0.6% for definite open-angle glaucoma.41 The incidence increased with age so that at age 60, the incidence was about 1% and it rose to 3% at age 80.As in most other studies, most of the patients with incident glaucoma were unaware of their disease. In Australia, the overall 5-year incidence of definite glaucoma in those over 40 was 0.5% and of definite and probable glaucoma 1.1%; the incidence ranges from near 0 at 40 to over 4% at age 80.42 A similar increase in incidence has been found in Minnesota.43
Intraocular pressure
There is general agreement that IOP is the most important known risk factor for open-angle glaucoma development. Evidence clearly indicates that elevated IOP can cause glaucomatous optic nerve changes in experimental animals.44,45 Even in normal-pressure glaucoma, asymmetric IOP has been noted to correlate with asymmetric cupping and field loss, with the greater damage most often occurring on the side with higher pressure.46,47 Population surveys also support the increase in prevalence of open-angle glaucoma with
Table 17-1 Prevalence of open-angle glaucoma
Investigator |
Site |
Ages (years) |
No. examined |
Diagnostic criteria |
Prevalence (%) |
|
|
|
|
|
|
Stromberg12 |
Skovde, Sweden |
40 |
7275 |
Disc and field changes |
0.41 |
Hollows & Graham13 |
Wales |
40–74 |
4231 |
Disc and field changes |
0.47 |
Bankes et al14 |
England |
40 |
5941 |
Disc and field changes |
0.76 |
Armaly15 |
Iowa |
20–89 |
2325 |
Arcuate scotoma |
4.08 |
Kahn & Milton16,17 |
Framingham, Mass |
52–85 |
2433 |
Visual field changes |
1.43 |
Bengtsson18 |
Dalby, Sweden |
55–70 |
1511 |
Disc and field changes |
0.86 |
Mason et al19 |
St Lucia, West Indies |
30–86 |
1679 |
Disc and field changes |
8.8 |
Tielsch et al20 |
Baltimore, Maryland (white) |
40 |
2913 |
Disc and field changes |
1.29 |
Tielsch et al20 |
Baltimore, Maryland (black) |
40 |
2395 |
Disc and field changes (black) |
4.74 |
Shiose et al21 |
Japan |
40 |
8126 |
Disc and field changes |
2.6 |
Klein et al22 |
Beaver Dam, Wisc |
43–84 |
4926 |
Disc and field changes |
2.1 |
Coffey et al23 |
Ireland |
50 |
2186 |
Disc and field changes |
1.9 |
Leske et al24 |
Barbados, West Indies |
40–84 |
4709 |
Disc and field changes |
6.6 |
Dielmans et al25 |
Rotterdam, Netherlands |
55 |
3062 |
Disc and field changes |
1.1 |
Mitchell et al26 |
Blue Mountain, Australia |
49 |
3654 |
Disc and field changes |
3.1 |
Friedman et al27 |
Estimate US |
40 |
Meta-analysis |
Disc and field changes |
1.9 |
Modified from Leske MC: Am J Epidemiol 118:166, 1983; Wilson MR, Martone JF: Epidemiology of chronic open-angle glaucoma. In: Ritch R, Shields MB, Krupin T, editors: The glaucomas, 2nd edn, St Louis, Mosby,1996.
240
|
chapter |
Primary open angle glaucoma |
17 |
|
|
increasing IOP.13,48,49 Among those with elevated IOP without evidence of glaucomatous damage (ocular hypertensives), the OHTS study shows that the higher the IOP, the more likely that glaucomatous damage will develop.50 Because many individuals with ‘elevated’ IOP never develop glaucoma, and because many people with glaucoma have ‘normal’ IOPs, IOP obviously cannot be the only risk factor.
Age
The prevalence of POAG increases with age (Table 17-2).13,20,22,48,51 However, one should not infer from this statement that the disease
is limited to middle-aged and older individuals; it occurs in children and young adults as well.52–54 The effect of age on the prevalence
of POAG holds true even after compensating for the relationship between increasing age and increasing IOP.55 Even in Japan where IOP does not increase with age, open-angle glaucoma does increase in prevalence with age.30 Age is also a risk factor for the conversion from ocular hypertension to open-angle glaucoma.50
Gender
Conflicting information exists about the effect of gender on the
prevalence of POAG. In several studies, males had a higher prevalence of glaucoma.16,24,25,56 In the Barbados study, POAG was asso-
ciated with older men, high IOP, positive family history, lean body mass, and low blood pressure to IOP ratio.57
Race
As noted above, POAG is more prevalent in blacks than in
whites.20,58 Furthermore, the disease seems to develop at an earlier age and has a more rapid progression in black patients.40,59–62 It is
estimated that the incidence and the prevalence of blindness from
glaucoma are 8–10 times higher in black patients than in white patients in the United States.20,63 The OHTS study showed black
race to be a risk factor for the development of open-angle glaucoma from ocular hypertension using univariate analysis; however, race drops out of the risk factors in the multivariate analysis because blacks have significantly thinner corneas than other racial groups and the thin corneas become the predominant risk factor.50 Some have proposed that optic nerve ischemia from sickle cell anemia contributes to the high prevalence of POAG in blacks. However, this theory
was not supported by one study, which found that only 2 of 40 black patients requiring filtering surgery had a positive test for sickle cell
trait.64 Black patients seem to respond to some treatment modes less favorably than do whites;65–68 whether this explains the more viru-
lent course has not been answered. Furthermore, some black patients may not have access to the same quality of treatment as white
patients have. When compared with whites, blacks have higher levels of IOP69–71 and larger cup-to-disc diameter ratios.72 In the USA,
in those of Hispanic (admittedly a very mixed group) background, the prevalence of open-angle glaucoma is midway between that of blacks and whites with a more rapid rise in prevalence as the population ages.73 Latinos of Mexican background living in Los Angeles also have a higher prevalence of open-angle glaucoma that is nearly 5% in those over 40; the prevalence is therefore somewhere between those of European ancestry and those of African ancestry.74
Data on the prevalence of POAG in other ethnic and racial groups are less complete. It is stated that POAG is rare in Pacific Islanders,75 some Asians,76–78 and certain Native American tribes. In Mongolia, the prevalence of open-angle glaucoma was found to be quite low (0.5%) with angle-closure glaucoma having a prevalence of 1.4%.79 In Japan, the prevalence of POAG is 0.58%, with normalpressure glaucoma having a prevalence of 2.04%.21 In an English study, the prevalence of open-angle glaucoma was found to be similar in those of European descent and in those of Asian descent.80 However, it is unlikely that this population living in England is representative of all Asian groups. In Tunis, the overall prevalence of open-angle glaucoma in a population over 40 years of age was 2.7%. This is similar to that found in Europeans but lower than that found in those of black African descent.81 In southern India (mostly Tamil), as noted above, the prevalence of open-angle glaucoma is 1.6% in those over 40.29 Further surveys using standardized techniques and definitions are needed in many population groups.
Socioeconomic factors
Very few studies have been performed on the relationship between socioeconomic variables and the prevalence of POAG. In different reports, manual laborers have an increased82 and a decreased83 prevalence of POAG.The Baltimore Eye Study suggested that socioeconomic factors played some role in the increased prevalence and severity of open-angle glaucoma in those of black African descent, but only a small part compared with racial factors.20A retrospective study from England looking for parameters contributing to blindness
Table 17-2 Prevalence of primary open-angle glaucoma by age (%)
Age (years) |
Wales (Hollows and |
Framingham, Mass. (Liebowitz |
Baltimore White (Tielsch and |
Baltimore Black (Tielsch |
|
Graham)13 |
and Co-workers)51 |
Co-workers)*20 |
and Co-workers)*20 |
40–49 |
NR |
NR |
0.92 |
1.23 |
50–54 |
0.3 |
NR |
|
|
55–59 |
0.9 |
0.5 |
0.41 |
4.05 |
60–64 |
0.5 |
0.7 |
|
|
65–69 |
1.1 |
0.9 |
0.88 |
5.51 |
70–74 |
1.3 |
1.7 |
|
|
75–79 |
NR |
2.0 |
2.89 |
9.15 |
80–85 |
NR |
4.4 |
2.16 |
11.26 |
Modified from Leske MC: Am J Epidemiol 118:166, 1983; Tielsch JM, and others: JAMA 266:369, 1991.. *Reported in decades (e.g., 50–59)
NR, not reported
241
part
4 CLINICAL ENTITIES
from glaucoma found that lower socioeconomic status was indeed one of the risk factors despite universal health care in that country.84 Little is known about the effect of lifestyle, vocation, geography, diet, and nutrition on glaucoma. Moderate exercise has been
shown to decrease IOP in both normal volunteers and in patients with POAG.85,86 Furthermore, moderate exercise has been shown to
increase choroidal blood flow, although with some limits.87 However, whether regular exercise results in better long-term IOP control or improved ganglion cell survival has not been demonstrated. One study showed little effect of caffeine on IOP but a more recent study
did implicate caffeine use as being related to increased IOP and to having glaucoma.88,89 It may be difficult in these kind of studies to
separate out the effects of a substance like caffeine and the effects of the total fluid volume associated with the intake.
Refractive error
Myopia has been associated with POAG in many studies.90–94 It is not clear whether myopia has a direct influence on the preva-
lence of the disease or whether it acts through its known associations with increased IOP and larger cup-to-disc ratios.95,96 It is
often difficult to diagnose glaucoma in myopic individuals because they have (1) broad, shallow optic cups with less distinct margins;
(2) baring of the blind spot or other refractive scotomata on visual field testing; (3) low ocular rigidity, which makes Schiøtz tonometer readings inaccurate, and (4) thin corneas and sclera which may give falsely low readings on Goldmann tonometry.
Corneal thickness
As noted previously, a thin cornea is a risk factor for conversion from ocular hypertension to open-angle glaucoma.1 Race as a risk factor in itself disappeared when corneal thickness was taken into account; that is, those of African ancestry had thinner corneas and this accounted for all of the increased risk for conversion to open-angle glaucoma among blacks with ocular hypertension. A thin cornea also seems to be a marker and possible risk factor for advanced glaucoma on diagnosis.97 A thin cornea will cause Goldmann tonometry to underestimate the IOP. In the OHTS study cited above, the increased risk related to thin corneas could not be explained solely by the underestimation of IOP. Therefore, thin corneas may be a marker for increased susceptibility of the optic nerve. Perhaps, people with thin corneas have less support tissue in the optic nerve making it more liable to pressure-induced and/or vascular damage.
Heredity
Primary open-angle glaucoma appears to have a genetic or famil-
ial component. Over the years, autosomal dominant,52,98 autosomal recessive,99,100 and sex-linked101 inheritance patterns have been
reported. Currently, most authorities believe that the genetic influence occurs through polygenic or multifactorial transmission. It is reported that 5–50% of cases of POAG are hereditary, with the best
estimate being 20–25%.102 The risk of developing POAG in firstdegree relatives is 4–16%.102–107 The Rotterdam study found that
relatives of patients with POAG were 10 times more likely to have or develop glaucoma than relatives of those without glaucoma.108 In Australia, the odds ratio for first-degree relatives is 3.1 and a positive family history was the strongest risk factor for development of glaucoma.109 A monozygotic and dizygotic twin study estimated the inheritability to be 13%.110 In a carefully done study of
laboratory-confirmed monozygotic twins and their spouses in Iceland, the concordance for open-angle glaucoma in the twins was 98%, much higher than in the spouse pairs.111 In one study, the association was higher with a sibling affected than with a parent or child.112 In the Barbados study, 25% of the siblings of patients with POAG had either POAG or were suspect for POAG.111 Siblings of those individuals with glaucoma are more likely to have a higher
IOP and a larger cup-to-disc ratio than siblings of those without glaucoma.113,114 Two longitudinal studies – one population-based
and the other over 18 years in length – demonstrated a strong asso-
ciation between the development of glaucoma and positive family history.58,115
Recently, studies have identified one gene (GLC1A) that is asso-
ciated with juvenile-onset open-angle glaucoma and some (about 3–4%) cases of POAG in adults.116,117 This gene is located on chro-
mosome 1 in the q23–25 region.118 Three different mutations of this gene have been identified in about 4% of patients with POAG.119 One particular mutation seems to account for most of the abnormal genes found in a population of glaucoma patients in India.120 This mutation was only present in about 5% of the total glaucoma population.Yet another mutation has been identified in a Chinese family with juvenile-onset open-angle glaucoma.121 Another gene that has been associated with adult-onset open-angle glaucoma is located on chromosome 2 (GLC1B).122 Both of these genes associated with POAG in adults seem to be related to an early-onset type. Some well-established pedigrees have had abnormalities in neither of these genes (see Ch. 20). Allingham and co-workers have identified a mutation on chromosome 15 that accounts for a relatively large subset (17%) of early, but not childhood-onset, glaucoma.123 Junemann and co-workers found a relatively high prevalence of polymorphisms in the methylenetetrahydrofolate reductase gene in POAG patients but not in exfoliative glaucoma patients in Germany.124 A group from Australia identified a novel gene abnormality on chromosome 3 which occurs in a large Tasmanian family with early-onset open-angle glaucoma, one-third of whom have mutations in the myocilin gene and others with glaucoma show mutations on chromosome 3.125 Another study found an association between an endothelial nitric oxide synthase gene and open-angle glaucoma accompanied by migraine.126
All these studies open an exciting frontier and suggest that openangle glaucoma may be associated with several different genes, each of which may produce a different time of onset and, perhaps, clinical course; furthermore, similar phenotypes can be seen with different mutations of different chromosomes even within the same family.The next few years should see some clarity in this area.
Several ocular factors associated with POAG – including IOP, out-
flow facility, and cup-to-disc ratio – appear to be genetically determined.127,128 For example, children and siblings of glaucoma patients
are far more likely to have abnormal aqueous humor dynamics than are first-degree relatives of normal individuals.129 Thus some of the polygenic inheritance of POAG may occur indirectly through these associated factors rather than directly through the disease itself.
Systemic factors
Primary open-angle glaucoma has been linked to a variety of endocrine and vascular disorders. Several studies have shown a high prev-
alence of diabetes mellitus in patients with POAG, as well as a high prevalence of POAG in patients with diabetes.130–134 Although nei-
ther the Baltimore Eye Study nor the Diabetes Audit and Research in Tayside Study (DARTS) in the United Kingdom were able to find
242
